Deinococcus radiodurans, although a gram-positive bacterium, has a complex cell wall with multiple layers and associates to this structural particularity, a quite unusual lipid composition for gram-positive bacteria. The conventional phospholipids (phosphatidyl ethanolamine, phosphatidyl choline, phosphatidyl glycerol...) are absent. Among the nine polar lipids detected in the R1 Anderson strain, three are glycolipids only one is a phospholipid, the other ones are glycophospholipids. One of the latter compounds contains one free amino group. Analysis by aminoacid autoanalyser enables to identify glucosamine in one glycolipid and in two glycophospholipids. Sugar analysis by gas-liquid chromatography after acid methanolysis and trifluoroacetylation, reveals the occurrence of N-acetyl glucosaminyl residues in one glycolipid and in one phospholipid. The following identification for the two lipids of D. radiodurans is proposed: phosphatidyl glucosaminyl glycerol and phosphatidyl N-acetyl glucosaminyl glycerol.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0300-9084(84)90009-9DOI Listing

Publication Analysis

Top Keywords

n-acetyl glucosaminyl
12
polar lipids
8
deinococcus radiodurans
8
glucosaminyl glycerol
8
glucosaminyl
5
phosphatidyl
5
lipids radiation
4
radiation resistant
4
resistant bacterium
4
bacterium deinococcus
4

Similar Publications

Matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) has been used to generate spatial maps of lipids, metabolites, peptides, proteins, and glycans in tissues; however, its use for mapping extracellular matrix (ECM) protein distributions is underexplored. ECM proteins play a major role in various pathological conditions, and changes in their spatial distributions affect the function and morphology of cells within tissues. ECM protein detection is challenging because they are large, insoluble, and undergo various post-translational modifications, such as glycosylation.

View Article and Find Full Text PDF

Characterization of Cell Surface Glycoproteins Using Enzymatic Treatment and Mass Spectrometry.

Anal Chem

December 2024

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.

Article Synopsis
  • * This research used enzymatic treatment and mass spectrometry to study changes in glycoproteins on the surface of renal cell carcinoma cells (A498) over different time points.
  • * The findings showed that combining enzymatic treatment with mass spectrometry effectively identifies cell surface glycoproteins and could aid in developing new targeted therapies.
View Article and Find Full Text PDF

Development of new NGLY1 assay systems - toward developing an early screening method for NGLY1 deficiency.

Glycobiology

September 2024

Glycometabolic Biochemistry Laboratory, RIKEN Cluster for Pioneering Research (CPR), Riken, 2-1 Hirosawa, Wako Saitama 351-0198, Japan.

Cytosolic peptide: N-glycanase (PNGase/NGLY1 in mammals) is an amidase (EC:3.5.1.

View Article and Find Full Text PDF
Article Synopsis
  • The protein PNGase helps manage other proteins by getting rid of the bad ones in our cells.
  • A mutation in the gene for PNGase can lead to a condition called NGLY1 deficiency, which is not good for health.
  • Scientists found out more about a related protein called FBS2, which might be a good target for new drugs to help treat NGLY1 deficiency.
View Article and Find Full Text PDF

The cytoplasmic peptide:N-glycanase (NGLY1) is ubiquitously expressed and functions as a de-N-glycosylating enzyme that degrades misfolded N-glycosylated proteins. NGLY1 deficiency due to biallelic loss-of-function NGLY1 variants is an ultrarare autosomal recessive deglycosylation disorder with multisystemic involvement; the neurological manifestations represent the main disease burden. Currently, there is no treatment for this disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!